PRMT5 is essential for B cell development and germinal center dynamics.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 01 2019
Historique:
received: 22 06 2018
accepted: 04 12 2018
entrez: 4 1 2019
pubmed: 4 1 2019
medline: 21 3 2019
Statut: epublish

Résumé

Mechanisms regulating B cell development, activation, education in the germinal center (GC) and differentiation, underpin the humoral immune response. Protein arginine methyltransferase 5 (Prmt5), which catalyzes most symmetric dimethyl arginine protein modifications, is overexpressed in B cell lymphomas but its function in normal B cells is poorly defined. Here we show that Prmt5 is necessary for antibody responses and has essential but distinct functions in all proliferative B cell stages in mice. Prmt5 is necessary for B cell development by preventing p53-dependent and p53-independent blocks in Pro-B and Pre-B cells, respectively. By contrast, Prmt5 protects, via p53-independent pathways, mature B cells from apoptosis during activation, promotes GC expansion, and counters plasma cell differentiation. Phenotypic and RNA-seq data indicate that Prmt5 regulates GC light zone B cell fate by regulating transcriptional programs, achieved in part by ensuring RNA splicing fidelity. Our results establish Prmt5 as an essential regulator of B cell biology.

Identifiants

pubmed: 30604754
doi: 10.1038/s41467-018-07884-6
pii: 10.1038/s41467-018-07884-6
pmc: PMC6318318
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
Prmt5 protein, mouse EC 2.1.1.319
Protein-Arginine N-Methyltransferases EC 2.1.1.319

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Références

Cancer Cell. 2013 May 13;23(5):677-92
pubmed: 23680150
Mol Cell. 2017 Mar 2;65(5):900-916.e7
pubmed: 28238654
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Mol Cell Biol. 2008 Oct;28(20):6262-77
pubmed: 18694959
Nat Commun. 2017 Oct 12;8(1):891
pubmed: 29026071
Mol Cell. 2009 Jan 16;33(1):1-13
pubmed: 19150423
Nat Rev Immunol. 2015 Mar;15(3):160-71
pubmed: 25698678
Science. 2016 Mar 11;351(6278):1214-8
pubmed: 26912360
Cell. 2000 Sep 1;102(5):553-63
pubmed: 11007474
Annu Rev Immunol. 2012;30:429-57
pubmed: 22224772
Nat Rev Immunol. 2014 Feb;14(2):69-80
pubmed: 24378843
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601
pubmed: 25480548
Blood. 2018 Nov 8;132(19):2026-2039
pubmed: 30082494
Immunity. 1997 Mar;6(3):225-33
pubmed: 9075923
Immunity. 2017 Jun 20;46(6):1045-1058.e6
pubmed: 28636954
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Leukemia. 2018 Feb;32(2):499-509
pubmed: 28663579
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Immunol. 2017 Aug;18(8):911-920
pubmed: 28628091
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Mol Cell. 2017 Jan 5;65(1):8-24
pubmed: 28061334
J Immunol. 2015 Aug 15;195(4):1538-47
pubmed: 26179907
Oncoscience. 2015 Aug 31;2(8):700-2
pubmed: 26425661
Mol Cell. 2001 May;7(5):1111-7
pubmed: 11389857
Nature. 2015 Jul 2;523(7558):96-100
pubmed: 25970242
Cancer Res. 2014 Mar 15;74(6):1752-65
pubmed: 24453002
Nat Med. 2011 Jul 17;17(8):996-1002
pubmed: 21765404
Nat Commun. 2011 Sep 06;2:465
pubmed: 21897376
EMBO J. 2007 Aug 8;26(15):3558-69
pubmed: 17627275
Genes Dev. 2010 Dec 15;24(24):2772-7
pubmed: 21159818
Cytometry. 1997 Nov 1;29(3):233-41
pubmed: 9389440
Cancer Discov. 2015 Mar;5(3):288-303
pubmed: 25582697
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Immunol Rev. 2000 Jun;175:158-74
pubmed: 10933601
Nat Rev Immunol. 2015 Mar;15(3):137-48
pubmed: 25656706
PLoS Genet. 2009 Jun;5(6):e1000514
pubmed: 19521535
Trends Biochem Sci. 2011 Dec;36(12):633-41
pubmed: 21975038
Oncogene. 2017 Jul 13;36(28):3943-3956
pubmed: 28288132
Nat Chem Biol. 2015 Jun;11(6):432-7
pubmed: 25915199
Nucleic Acids Res. 1997 Mar 15;25(6):1317-8
pubmed: 9092650
Nat Cell Biol. 2008 Dec;10(12):1431-9
pubmed: 19011621
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
FEBS Lett. 2016 Apr;590(8):1200-10
pubmed: 27013173
Mol Immunol. 2009 Mar;46(6):1031-41
pubmed: 19181385
Cell. 2013 May 23;153(5):988-99
pubmed: 23706737
Immunity. 2018 Apr 17;48(4):702-715.e4
pubmed: 29669250
Mol Cell. 2014 Nov 20;56(4):564-79
pubmed: 25457166
Nature. 1995 Oct 12;377(6549):552-7
pubmed: 7566157
J Clin Invest. 2015 Sep;125(9):3532-44
pubmed: 26258414
J Biol Chem. 2004 Oct 22;279(43):44825-33
pubmed: 15310756
Nat Immunol. 2018 Nov;19(11):1265-1276
pubmed: 30323341
Sci Signal. 2011 Sep 13;4(190):ra58
pubmed: 21917714
Nat Rev Cancer. 2013 Jan;13(1):37-50
pubmed: 23235912
J Immunol. 2009 Jun 15;182(12):7595-602
pubmed: 19494283
J Exp Med. 2007 May 14;204(5):1145-56
pubmed: 17452520
J Exp Med. 2010 Apr 12;207(4):711-9
pubmed: 20231378
Genes Dev. 1996 Aug 15;10(16):2038-54
pubmed: 8769647
Cell Host Microbe. 2008 Oct 16;4(4):362-73
pubmed: 18854240
Genes Dev. 2013 Sep 1;27(17):1903-16
pubmed: 24013503
Nature. 2010 Nov 4;468(7320):112-6
pubmed: 20962777
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7396-401
pubmed: 16651521
Nat Immunol. 2012 Nov;13(11):1083-91
pubmed: 23001145
Curr Biol. 1994 Jan 1;4(1):1-7
pubmed: 7922305
FEBS Lett. 2013 Apr 2;587(7):880-6
pubmed: 23402884
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13789-94
pubmed: 16940357
Microbiol Immunol. 2013 Mar;57(3):185-92
pubmed: 23278594
J Immunol. 2013 Jun 15;190(12):5949-60
pubmed: 23667108
Cell Rep. 2018 Sep 4;24(10):2643-2657
pubmed: 30184499
Cell. 2010 Nov 12;143(4):592-605
pubmed: 21074050

Auteurs

Ludivine C Litzler (LC)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.
Department of Biochemistry and molecular medicine, 2900 boul. Édouard-Montpetit, bureau D-360, Montréal, QC, H3T 1J4, Canada.

Astrid Zahn (A)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.

Alexandre P Meli (AP)

Meakins-Christie Laboratories, Department of Microbiology and Immunology, McGill University Health Centre, 1001 boul. Decarie, Block E (EM2.2232), Montreal, QC, H4A 3J1, Canada.

Steven Hébert (S)

Segal Cancer Center, Lady Davis Institute for Medical Research, Montréal, Québec, H3T 1E2, Canada.

Anne-Marie Patenaude (AM)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.
Genos, BioCentar Borongajska cesta 83H, 10000, Zagreb, Croatia.

Stephen P Methot (SP)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.
Friedrich Miescher Institute for Biomedical Research, R-1066.2.58. P.O. Box 3775,, Maulbeerstrasse 66, 4002, Basel, Switzerland.

Adrien Sprumont (A)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.

Thérence Bois (T)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada.

Daisuke Kitamura (D)

Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, 278-0022, Japan.

Santiago Costantino (S)

Research Center of the Hospital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montréal, H1T 2M4, QC, Canada.
Department of Ophthalmology, Université de Montréal, C.P. 6128, succ. Centre-ville, Montréal, QC, H3C 3J7, Canada.

Irah L King (IL)

Meakins-Christie Laboratories, Department of Microbiology and Immunology, McGill University Health Centre, 1001 boul. Decarie, Block E (EM2.2232), Montreal, QC, H4A 3J1, Canada.

Claudia L Kleinman (CL)

Segal Cancer Center, Lady Davis Institute for Medical Research, Montréal, Québec, H3T 1E2, Canada.
Department of Human Genetics, Faculty of Medicine, McGill University, 1205 Dr. Penfield Ave, Montréal, Quebec, H3A 1B1, Canada.

Stéphane Richard (S)

Segal Cancer Center, Lady Davis Institute for Medical Research, Montréal, Québec, H3T 1E2, Canada.
Departments of Oncology and Medicine, McGill University, 5100 Maisonneuve Blvd West, Suite 720, Montreal, QC, H4A3T2, Canada.

Javier M Di Noia (JM)

Institut de Recherches Cliniques de Montréal, 110 av. des Pins Ouest, Montréal, QC, H2W 1R7, Canada. javier.di.noia@ircm.qc.ca.
Department of Biochemistry and molecular medicine, 2900 boul. Édouard-Montpetit, bureau D-360, Montréal, QC, H3T 1J4, Canada. javier.di.noia@ircm.qc.ca.
Department of Medicine, Division of Experimental Medicine, McGill University, 1001 boul Decarie, Montreal, QC, H4A 3J1, Canada. javier.di.noia@ircm.qc.ca.
Department of Medicine, Université de Montréal, C.P. 6128, succ. Centre-ville, Montréal, QC, H3C 3J7, Canada. javier.di.noia@ircm.qc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH